Indegene Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Indegene Ltd · Outcome · 30 Oct 2026, 1:07 am
Indegene Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 11,223 (+39.6% YoY | +5.6% QoQ) ■ EBITDA: 1,857 (+32.1% YoY | +6.6% QoQ) ■ EBITDA Margin (%): 16.5 (-94 bps YoY | +16 bps QoQ) ■ PAT: 1,123 (+10.0% YoY | -3.4% QoQ) ■ EPS (INR): 4.64 (+9.7% YoY | -3.5% QoQ) Indegene Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Enterprise Medical Solutions ■ Revenue: 2,753 (+22.8% YoY | +0.6% QoQ) ■ EBIT: 626 (+8.9% YoY | -12.6% QoQ) ■ EBIT Margin (%): 22.7 (-291 bps YoY | -343 bps QoQ) Enterprise Commercial Solutions ■ Revenue: 8,002 (+45.2% YoY | +6.7% QoQ) ■ EBIT: 1,302 (+32.6% YoY | +8.8% QoQ) ■ EBIT Margin (%): 16.3 (-154 bps YoY | +32 bps QoQ) Others ■ Revenue: 468 (+62.5% YoY | +19.1% QoQ) ■ EBIT: 3.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 0.6 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Indegene Ltd
- Intimation of Investors / Analysts Meeting · 06 Nov 2026
- Transcript of the Q2 FY27 Earnings Call · 04 Nov 2026
- Audio Recording of the Q2 FY27 Earnings Call · 30 Oct 2026
- Audio Recording of the Q2 FY27 Earnings Call · 30 Oct 2026
- Analyst Presentation and Fact Sheet - financial results for the 2nd quarter and half year ended 30th September, 2026 · 30 Oct 2026
- Press Release · 30 Oct 2026
- Indegene Limited has informed the Exchange regarding Resignation of Ms Srishti Ramesh Kaushik as Company Secretary & Compliance Officer of the company w.e.f. December 02, 2026. · 30 Oct 2026
- Intimation of Resignation of Ms. Srishti Ramesh Kaushik (M. No A21609) from the position of Company Secretary, Compliance Officer and Key Managerial Personnel of the Company. · 30 Oct 2026
